Trial opens door for more testing of hepatitis C vaccine

01/9/2012 | Medical News Today

British researchers used an adenoviral vector strategy to develop a vaccine that can strengthen T cells' response against the hepatitis C virus. The study, published in the journal Science Translational Medicine, found the vaccine to be safe. Researchers are working on a second-stage trial among people infected with the virus, and a U.S. trial is being planned to study whether the vaccine can protect people at risk of infection.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX